Uncategorized
Bacterial Trait-Finding and Gene Mapping Platform Speeds Microbial Engineering for Biotech Applications
Scientists at the Department of Energy’s Oak Ridge National Laboratory (ORNL) have created a platform that can pinpoint genetic triggers that turn microbes into efficient factories for new chemicals and materials. The platform identifies specific genetic triggers for useful complex traits, supporting the design and reprogramming of microbes that exhibit targeted capabilities. Potential applications of such bacterial factories might include the breakdown and conversion of plant lignin into valuable products, or the uptake of critical minerals.
The team’s approach, which combines synthetic biology expertise, artificial intelligence, and statistical mapping techniques, enables rapid, precise reprogramming of bacteria as biotechnology tools, and builds on previous work by ORNL scientists, who adapted a technique called protoplast fusion to create the diverse microbial offspring needed for genetic mapping. “Unlike past approaches that study the effect of gaining or losing whole genes, the new approach lets us determine how small differences in the nucleotide sequence affect bacterial function,” said Josh Michener, PhD, project co-lead and Biological Systems Design group leader at ORNL. “Variations in strains at the nucleotide level have a huge impact on the resulting phenotype, especially when you’re engineering microbes with specific mutations. The method also lets us study natural mutations in parental strains that make them ideal biotechnology tools.”
Michener is co-senior and co-corresponding author of the team’s report in Nature Communications (“Genome shuffling enables quantitative trait locus mapping in Bacillus subtilis”) in which they reported on the development of their platform and its validation using gene editing in bacteria.
To determine which genes control certain characteristics in organisms, scientists have used a method called quantitative trait locus (QTL) mapping. QTL mapping involves analyzing the traits of lots of varied offspring from two distinct parents, and is a common approach in mapping the genes of other organisms such as plants. The method examines many genetic differences at once and precisely identifies candidate genes in a single workflow.
However, linking DNA sequences to observable physical traits in bacteria is challenging, the authors noted. “Even in the best-studied model bacteria, many genes have unknown functions, and little is known about the genetic networks underlying complex phenotypes or the functional effects of natural sequence variation in bacterial genes and regulatory elements.”
The problem with applying QTL mapping to bacteria is that these microorganisms reproduce asexually with limited genetic variation. “Quantitative trait locus (QTL) mapping generally relies on sexual recombination to break linkages between genes, yet bacteria rarely undergo sufficient homologous recombination to generate suitable mapping populations,” the team continued.
ORNL researchers overcame the hurdles associated with applying QTL to bacteria using protoplast fusion, a tool first developed in the 1970s. Using the fusion technique, researchers were able to cross Bacillus strains, producing a large population of genetically varied offspring, called recombinants. “We have previously shown that genome shuffling by protoplast fusion between genetically diverse Bacillus strains generates frequent, unbiased, genome-wide recombination that mimics the effects of sexual recombination,” they noted. Bacillus are model bacteria that serve as workhorses for fermentation, enzyme production, and plant growth and health. Referring to their newly published paper, the team added, “In this study, we leveraged protoplast fusion to establish a bacterial QTL mapping platform.”
Researchers measured properties of the bacteria and identified DNA variants that could explain the differences in those traits. The team tested the method across several other bacterial groups, demonstrating alternative genome shuffling methods that expand the tool’s usability on different types of microbes used as biotechnology tools. These included Clostridium thermocellum, a bacterium that tolerates industrial processes and is good at breaking down and fermenting plant cellulose. Also in Novosphingobium aromaticivorans, a bacterium that excels at breaking down aromatic compounds from plant lignin and converting the molecules into high-value chemicals. Also in Stutzerimonas stutzeri, a versatile bacterium used in applications such as bioremediation and to fix nutrients in soil, supporting plant growth and suppressing plant pathogens.
They validated their findings by using CRISPR gene editing tools to swap gene sections and confirm the effects in bacteria. “We have now, for the first time ever, put all these pieces together for a platform that gets results on complex genes-to-traits linkages much faster,” Michener said. “We built the genetically diverse bacteria population, identified DNA variants, and confirmed the work with gene editing.”
The authors added, “In contrast to traditional loss-of-function and gain-of-function genetic methods, our approach enables rapid detection of the effects of natural genetic variation in both coding and noncoding regions on bacterial phenotypes, beyond gene presence or absence.”
By creating such broad diversity in the bacterial offspring, scientists faced a challenge in the research: phenotyping all the progeny. They tackled it with automation and AI, setting up a robotic system to quickly and repeatedly place plates with precision so that high-resolution digital imaging could be accomplished at the same angle and lighting for comparable data between the recombinants. The phenotyping was accomplished 10 times faster with automation, the scientists noted.
Getting consistent data was crucial to the application of mathematical algorithms and the use of a computer vision model that processed the images and extracted traits, explained co-lead Dan Jacobson, ORNL computational systems biologist. “We built this project with a very multidisciplinary lineup,” Jacobson said. “The team did everything from building the robotics, conducting imaging and image processing, performing the statistical work, the mapping and assemblies, the genome shuffling work, growing these different isolates from the population and extracting DNA to send for sequencing, then growing them again for the phenotype assays. It’s an example of the kind of good collaboration that’s possible at a national lab, and how that research can enable whole new areas of inquiry across the nation’s science ecosystem.”
Scientists continue to deploy the method to study and engineer microbes for better manufacturing processes as part of the DOE Center for Bioenergy Innovation (CBI) at ORNL. The platform is also being used to study plant-associated microbes as part of the DOE Secure Ecosystem Engineering and Design Science Focus Area (SEED SFA), as well as by a program at Colorado State University studying airborne microbes.
The microbial QTL mapping platform is available for licensing at ORNL.
The post Bacterial Trait-Finding and Gene Mapping Platform Speeds Microbial Engineering for Biotech Applications appeared first on GEN – Genetic Engineering and Biotechnology News.
Uncategorized
New webinar: Tackling drug discovery challenges in cancer research

Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development.
You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics and Lars van der Veen, Chief Scientific Officer at iOnctura.
Presentations will cover how cancer treatments have shifted towards reprogramming the biology driving tumour growth, immune escape and treatment resistance, the trajectory that in vivo CAR-T treatments are taking, and how challenging tumours burdened by stroma and immune-mediated resistance can be tackled.
Q&A with the speakers follows the presentations.
The post New webinar: Tackling drug discovery challenges in cancer research appeared first on Drug Discovery World (DDW).
Uncategorized
Psilocybin proves promising in neuropathic pain mouse study
Amid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a treatment for chemotherapy-induced peripheral neuropathy.
Uncategorized
New Spectrometry Technique Could Aid Formulation Development
New Spectrometry Technique Could Aid Formulation Development
A new technique combining two forms of spectrometry could help biopharmaceutical companies improve their choice of formulation buffer for antibody manufacturing by revealing how molecular forms and three-dimensional shapes of complex biologics respond to their environment. That’s the view of Christian Bleiholder, PhD, a professor at Florida State University who helped develop the technique.
According to Bleiholder, what happens structurally when a complex biological molecule, such as an antibody or viral spike protein, binds to its target is currently poorly understood.
“This is where [this approach] can help with the bioprocessing and formulation,” he says, as structural changes “can affect the lifespan [of the product] and lead to issues, such as aggregation.”
Because antibodies are complex, existing techniques tend to be powerful at different levels of complexity, he explains. Mass spectrometry is particularly powerful for distinguishing molecular composition, while structural approaches such as X-ray crystallography and cryo-electron microscopy can provide high-resolution structural information.
The challenge is understanding the link between these things within a heterogeneous sample, he says.
To overcome this, Bleiholder and his team worked with Bruker Daltonics to develop Tandem-Trapped Ion Mobility Spectrometry (Tandem-TIMS). This combines tandem ion mobility spectrometry with tandem mass spectrometry to disentangle three overlapping layers of molecular complexity: molecular form, three-dimensional shape, and binding or assembly state, he says.
He explains that, if the proteins have different structures, they can be characterized with tandem ion mobility spectrometry, and then mass spectrometry can be used to look at their molecular forms and binding states.
Going forward, Bleiholder hopes the technique can be used for formulation development but also earlier, during drug discovery of new products, such as multi-specific antibodies, to determine which molecular states are important and how those change when a biologic engages its target. He also plans to look at automating the technique.
Bleiholder spoke about using Tandem-TIMS at the Bioprocessing Summit in Boston earlier this year.
The post New Spectrometry Technique Could Aid Formulation Development appeared first on GEN – Genetic Engineering and Biotechnology News.
-
Uncategorized8 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Endpoints News8 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized7 months agoOptical Pooled CRISPR Screen Reveals Regulators of NF-κB Dynamics in Human Cells
-
Uncategorized6 months ago
Relay’s PI3Kα inhibitor clears efficacy bar in Phase 2 vascular anomalies study
-
Uncategorized6 months ago
Hybrid solid−liquid optics enable scalable, high-resolution light-sheet microscopy across diverse immersion media
-
Fierce Biotech8 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Nature Biotechnology8 months ago
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
-
Nature Biotechnology8 months ago
Mapping cis-regulatory mutations at scale in sorghum enables modulation of gene expression
Scan to Read